Impact of Hepatitis B Exposure on Sustained Virological Response Rates of Highly Viremic Chronic Hepatitis C Patients

Aim. To evaluate the impact of hepatitis B core antibody (anti-HBc) seropositivity in sustained virological response (SVR) rates in treatment-naïve, chronic hepatitis C (CHC) patients with high pretreatment viral load (>800000 IU/mL). Methods. 185 consecutive CHC patients (14.4% cirrhotics, 70.2%...

Full description

Saved in:
Bibliographic Details
Main Authors: Ioannis S. Elefsiniotis, Christos Pavlidis, Elena Vezali, Theodoros Mariolis-Sapsakos, Sotirios Koutsounas, George Saroglou
Format: Article
Language:English
Published: Wiley 2009-01-01
Series:Gastroenterology Research and Practice
Online Access:http://dx.doi.org/10.1155/2009/812140
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832555459117056000
author Ioannis S. Elefsiniotis
Christos Pavlidis
Elena Vezali
Theodoros Mariolis-Sapsakos
Sotirios Koutsounas
George Saroglou
author_facet Ioannis S. Elefsiniotis
Christos Pavlidis
Elena Vezali
Theodoros Mariolis-Sapsakos
Sotirios Koutsounas
George Saroglou
author_sort Ioannis S. Elefsiniotis
collection DOAJ
description Aim. To evaluate the impact of hepatitis B core antibody (anti-HBc) seropositivity in sustained virological response (SVR) rates in treatment-naïve, chronic hepatitis C (CHC) patients with high pretreatment viral load (>800000 IU/mL). Methods. 185 consecutive CHC patients (14.4% cirrhotics, 70.2% prior intravenous drug users) treated with pegylated interferon-a2b plus ribavirin, for 24 or 48 weeks based on viral genotype, were retrospectively analyzed. SVR was confirmed by undetectable serum HCV-RNA six months after the end of treatment schedule. Results. Thirty percent of CHC/HBsAg-negative patients were anti-HBc-positive. Anti-HBc positivity was more prevalent in cirrhotic, compared to noncirrhotic patients (76.9% versus 19.5%, P<.05). Serum HBV-DNA was detected in the minority of anti-HBc-positive patients (1.97%). Overall, 62.1% of patients exhibited SVR, while 28.6% did not; 71.4% of non-SVRs were infected with genotype 1. In the univariate analysis, the anti-HBc positivity was negatively associated with treatment outcome (P=.065). In the multivariate model, only the advanced stage of liver disease (P=.015) and genotype-1 HCV infection (P=.003), but not anti-HBc-status (P=.726), proved to be independent predictors of non-SVR. Conclusion. Serum anti-HBc positivity does not affect the SVR rates in treatment-naïve CHC patients with high pretreatment viral load, receiving the currently approved combination treatment.
format Article
id doaj-art-43065c0cd0fe4374b1357b599e4a8384
institution Kabale University
issn 1687-6121
1687-630X
language English
publishDate 2009-01-01
publisher Wiley
record_format Article
series Gastroenterology Research and Practice
spelling doaj-art-43065c0cd0fe4374b1357b599e4a83842025-02-03T05:48:03ZengWileyGastroenterology Research and Practice1687-61211687-630X2009-01-01200910.1155/2009/812140812140Impact of Hepatitis B Exposure on Sustained Virological Response Rates of Highly Viremic Chronic Hepatitis C PatientsIoannis S. Elefsiniotis0Christos Pavlidis1Elena Vezali2Theodoros Mariolis-Sapsakos3Sotirios Koutsounas4George Saroglou5University Department of Internal Medicine, Hepatology Unit, “Elena Venizelou” Hospital, 11521 Athens, GreeceReference Center for Viral Hepatitis, I.K.A, Athens, GreeceUniversity Department of Internal Medicine, Hepatology Unit, “Elena Venizelou” Hospital, 11521 Athens, GreeceUniversity Department of Internal Medicine, Hepatology Unit, “Elena Venizelou” Hospital, 11521 Athens, GreeceReference Center for Viral Hepatitis, I.K.A, Athens, GreeceUniversity Department of Internal Medicine, Hepatology Unit, “Elena Venizelou” Hospital, 11521 Athens, GreeceAim. To evaluate the impact of hepatitis B core antibody (anti-HBc) seropositivity in sustained virological response (SVR) rates in treatment-naïve, chronic hepatitis C (CHC) patients with high pretreatment viral load (>800000 IU/mL). Methods. 185 consecutive CHC patients (14.4% cirrhotics, 70.2% prior intravenous drug users) treated with pegylated interferon-a2b plus ribavirin, for 24 or 48 weeks based on viral genotype, were retrospectively analyzed. SVR was confirmed by undetectable serum HCV-RNA six months after the end of treatment schedule. Results. Thirty percent of CHC/HBsAg-negative patients were anti-HBc-positive. Anti-HBc positivity was more prevalent in cirrhotic, compared to noncirrhotic patients (76.9% versus 19.5%, P<.05). Serum HBV-DNA was detected in the minority of anti-HBc-positive patients (1.97%). Overall, 62.1% of patients exhibited SVR, while 28.6% did not; 71.4% of non-SVRs were infected with genotype 1. In the univariate analysis, the anti-HBc positivity was negatively associated with treatment outcome (P=.065). In the multivariate model, only the advanced stage of liver disease (P=.015) and genotype-1 HCV infection (P=.003), but not anti-HBc-status (P=.726), proved to be independent predictors of non-SVR. Conclusion. Serum anti-HBc positivity does not affect the SVR rates in treatment-naïve CHC patients with high pretreatment viral load, receiving the currently approved combination treatment.http://dx.doi.org/10.1155/2009/812140
spellingShingle Ioannis S. Elefsiniotis
Christos Pavlidis
Elena Vezali
Theodoros Mariolis-Sapsakos
Sotirios Koutsounas
George Saroglou
Impact of Hepatitis B Exposure on Sustained Virological Response Rates of Highly Viremic Chronic Hepatitis C Patients
Gastroenterology Research and Practice
title Impact of Hepatitis B Exposure on Sustained Virological Response Rates of Highly Viremic Chronic Hepatitis C Patients
title_full Impact of Hepatitis B Exposure on Sustained Virological Response Rates of Highly Viremic Chronic Hepatitis C Patients
title_fullStr Impact of Hepatitis B Exposure on Sustained Virological Response Rates of Highly Viremic Chronic Hepatitis C Patients
title_full_unstemmed Impact of Hepatitis B Exposure on Sustained Virological Response Rates of Highly Viremic Chronic Hepatitis C Patients
title_short Impact of Hepatitis B Exposure on Sustained Virological Response Rates of Highly Viremic Chronic Hepatitis C Patients
title_sort impact of hepatitis b exposure on sustained virological response rates of highly viremic chronic hepatitis c patients
url http://dx.doi.org/10.1155/2009/812140
work_keys_str_mv AT ioannisselefsiniotis impactofhepatitisbexposureonsustainedvirologicalresponseratesofhighlyviremicchronichepatitiscpatients
AT christospavlidis impactofhepatitisbexposureonsustainedvirologicalresponseratesofhighlyviremicchronichepatitiscpatients
AT elenavezali impactofhepatitisbexposureonsustainedvirologicalresponseratesofhighlyviremicchronichepatitiscpatients
AT theodorosmariolissapsakos impactofhepatitisbexposureonsustainedvirologicalresponseratesofhighlyviremicchronichepatitiscpatients
AT sotirioskoutsounas impactofhepatitisbexposureonsustainedvirologicalresponseratesofhighlyviremicchronichepatitiscpatients
AT georgesaroglou impactofhepatitisbexposureonsustainedvirologicalresponseratesofhighlyviremicchronichepatitiscpatients